Physician profile
Michael Hoffman
NPI 1467790394
$2,402.10
in general payments reported to CMS, 2019-2025
18 companies · $390 in 2025
The $390 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $358 · 2022: $44.07 · 2023: $750 · 2024: $859 · 2025: $390.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,999.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $650.25 | 2021-2025 | |
| Glaxosmithkline, LLC. | $415.59 | 2021-2023 | Arexvy, Shingrix |
| Novo Nordisk INC | $284.91 | 2023-2025 | Wegovy, Rybelsus, Ozempic |
| Amgen INC. | $246.71 | 2023-2025 | Repatha, Otezla, Otezla |
| Intra-Sana Laboratories | $133.31 | 2023 | Reltone 400 Mg, Glycate, Reltone 200 Mg |
| Lilly USA, LLC | $110.33 | 2022-2024 | Mounjaro |
| Merck Sharp & Dohme LLC | $104.55 | 2023-2024 | Gardasil 9, Gardasil, Vaxneuvance |
| Relievant Medsystems, INC. | $97.47 | 2021 | |
| Pfizer INC. | $87.33 | 2022-2024 | |
| Inspire Medical Systems, INC. | $51.25 | 2024 | Inspire |
| Esperion Therapeutics, INC. | $50.00 | 2024 | Nexletol |
| Sumitomo Pharma America, INC. | $39.05 | 2024 | Gemtesa |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $30.99 | 2021 | |
| Amarin Pharma, INC. | $22.31 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $22.24 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $21.96 | 2024 | Cologuard Collection Kit |
| Alkermes, INC. | $21.38 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.47 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Hoffman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.